Source:http://linkedlifedata.com/resource/pubmed/id/18001087
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2007-12-28
|
pubmed:abstractText |
Luteibacter sp., a new bacterium isolated from the soil around a Taxus cuspidata Sieb. et Zucc plant, was studied for its capability to metabolize cephalomannine (1). After preparative fermentation, eight metabolites were obtained and characterized as baccatin III (2), baccatin V (3), 10-deacetylbaccatin III (4), 10-deacetyl-10-oxobaccatin V (5), 7-epicephalomannine (6), 10-deacetylcephalomannine (7), 10-deacetyl-7-epicephalomannine (8), and 3'-N-debenzoyl-3'-N-(2-methylbutyryl)-7-epitaxol (9). Among these metabolites, 9 is a new compound. Epimerization of the 7beta-OH group and hydrolysis of the C-13 side-chain were the two major reactions in this bioprocess. However, the biotransformation of 7beta-D-xylosyl-10-deacetyltaxol (10) with the same strain yielded a C-13 side-chain eliminated product without epimerization at C-7 (11). Metabolites 5-9 and 11, together with 1 and paclitaxel, were evaluated for their inhibitory activities against five human cancer cell lines (HCT-8, Bel-7402, BGC-823, A549, and A2780). All these compounds showed less potent activities than paclitaxel, which is currently used in clinical chemotherapy.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/10-deacetylbaccatine III,
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/baccatin III,
http://linkedlifedata.com/resource/pubmed/chemical/cephalomannine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0163-3864
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1846-9
|
pubmed:dateRevised |
2008-5-28
|
pubmed:meshHeading |
pubmed-meshheading:18001087-Alkaloids,
pubmed-meshheading:18001087-Antineoplastic Agents,
pubmed-meshheading:18001087-Bacteria,
pubmed-meshheading:18001087-Drug Screening Assays, Antitumor,
pubmed-meshheading:18001087-Humans,
pubmed-meshheading:18001087-Molecular Structure,
pubmed-meshheading:18001087-Paclitaxel,
pubmed-meshheading:18001087-Soil Microbiology,
pubmed-meshheading:18001087-Taxoids,
pubmed-meshheading:18001087-Taxus
|
pubmed:year |
2007
|
pubmed:articleTitle |
Microbial transformation of cephalomannine by Luteibacter sp.
|
pubmed:affiliation |
Department of Biosynthesis of Natural Products, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|